250 related articles for article (PubMed ID: 20947021)
61. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers.
Cheskis B; Freedman LP
Mol Cell Biol; 1994 May; 14(5):3329-38. PubMed ID: 8164684
[TBL] [Abstract][Full Text] [Related]
62. Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers.
Sánchez-Martínez R; Zambrano A; Castillo AI; Aranda A
Mol Cell Biol; 2008 Jun; 28(11):3817-29. PubMed ID: 18362166
[TBL] [Abstract][Full Text] [Related]
63. Vitamin D receptor contains multiple dimerization interfaces that are functionally different.
Nishikawa J; Kitaura M; Imagawa M; Nishihara T
Nucleic Acids Res; 1995 Feb; 23(4):606-11. PubMed ID: 7899080
[TBL] [Abstract][Full Text] [Related]
64. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
Matkovits T; Christakos S
Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
[TBL] [Abstract][Full Text] [Related]
65. Differential hydrogen/deuterium exchange mass spectrometry analysis of protein-ligand interactions.
Chalmers MJ; Busby SA; Pascal BD; West GM; Griffin PR
Expert Rev Proteomics; 2011 Feb; 8(1):43-59. PubMed ID: 21329427
[TBL] [Abstract][Full Text] [Related]
66. Dynamics and ligand-induced solvent accessibility changes in human retinoid X receptor homodimer determined by hydrogen deuterium exchange and mass spectrometry.
Yan X; Broderick D; Leid ME; Schimerlik MI; Deinzer ML
Biochemistry; 2004 Feb; 43(4):909-17. PubMed ID: 14744134
[TBL] [Abstract][Full Text] [Related]
67. Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains.
Bury Y; Herdick M; Uskokovic MR; Carlberg C
J Cell Biochem Suppl; 2001; Suppl 36():179-90. PubMed ID: 11455583
[TBL] [Abstract][Full Text] [Related]
68. Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions.
Norman AW; Manchand PS; Uskokovic MR; Okamura WH; Takeuchi JA; Bishop JE; Hisatake JI; Koeffler HP; Peleg S
J Med Chem; 2000 Jul; 43(14):2719-30. PubMed ID: 10893309
[TBL] [Abstract][Full Text] [Related]
69. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor.
Liu YY; Collins ED; Norman AW; Peleg S
J Biol Chem; 1997 Feb; 272(6):3336-45. PubMed ID: 9013574
[TBL] [Abstract][Full Text] [Related]
70. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
Kimmel-Jehan C; Jehan F; DeLuca HF
Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
[TBL] [Abstract][Full Text] [Related]
71. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
72. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands.
Tocchini-Valentini G; Rochel N; Wurtz JM; Mitschler A; Moras D
Proc Natl Acad Sci U S A; 2001 May; 98(10):5491-6. PubMed ID: 11344298
[TBL] [Abstract][Full Text] [Related]
73. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function.
Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D
Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610
[TBL] [Abstract][Full Text] [Related]
74. Histidine hydrogen-deuterium exchange mass spectrometry for probing the microenvironment of histidine residues in dihydrofolate reductase.
Miyagi M; Wan Q; Ahmad MF; Gokulrangan G; Tomechko SE; Bennett B; Dealwis C
PLoS One; 2011 Feb; 6(2):e17055. PubMed ID: 21359214
[TBL] [Abstract][Full Text] [Related]
75. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3.
Cheskis B; Lemon BD; Uskokovic M; Lomedico PT; Freedman LP
Mol Endocrinol; 1995 Dec; 9(12):1814-24. PubMed ID: 8614417
[TBL] [Abstract][Full Text] [Related]
76. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
77. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
Thummel KE; Brimer C; Yasuda K; Thottassery J; Senn T; Lin Y; Ishizuka H; Kharasch E; Schuetz J; Schuetz E
Mol Pharmacol; 2001 Dec; 60(6):1399-406. PubMed ID: 11723248
[TBL] [Abstract][Full Text] [Related]
78. Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis.
Ciesielski F; Rochel N; Mitschler A; Kouzmenko A; Moras D
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):55-9. PubMed ID: 15225747
[TBL] [Abstract][Full Text] [Related]
79. Heterodimer requirement for gene regulation by Vitamin D in variant OK cells.
Koszewski NJ; Rowan A
Steroids; 2003 Apr; 68(4):307-14. PubMed ID: 12787891
[TBL] [Abstract][Full Text] [Related]
80. The retinoid X receptor ligand restores defective signalling by the vitamin D receptor.
Sánchez-Martínez R; Castillo AI; Steinmeyer A; Aranda A
EMBO Rep; 2006 Oct; 7(10):1030-4. PubMed ID: 16936639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
